Home
Home

myelofibrosis

Geron says FDA halts patient enrollment in another cancer trial

Geron says FDA halts patient enrollment in another cancer trial
Yahoo/Reuters

Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary

Clinical Trial Hold Of Geron's Revolutionary Drug Imetelstat Will Be Temporary
Seeking Alpha

Geron Plummets as FDA Halts Development of Blood Disorder Drug

Geron Plummets as FDA Halts Development of Blood Disorder Drug
Bloomberg

Geron Shares React to Imetelstat Mayo Study Update

Geron Shares React to Imetelstat Mayo Study Update
TheStreet.com

Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today

Keep an Eye on Geron, Novartis, Cell Therapeutics, and Verastem Today
Motley Fool

Geron Soars After Study Shows Bone Marrow Drug’s Benefit

Geron Soars After Study Shows Bone Marrow Drug’s Benefit
Bloomberg

Whither Sanofi R&D? Another Setback For An Oncology Drug

Whither Sanofi R&D? Another Setback For An Oncology Drug
Pharmalot

Baxter, Cell Therapeutics announce collaboration to develop pacritinib

Baxter, Cell Therapeutics announce collaboration to develop pacritinib
Yahoo/Fly on the Wall

Geron soars after myelofibrosis drug shows 44% response rate

Geron soars after myelofibrosis drug shows 44% response rate
The Fly on the Wall

Incyte Has First-Mover Advantage

Incyte Has First-Mover Advantage
Motley Fool